{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:25:47Z","timestamp":1777519547727,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020141","name":"Akebia Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.hlc.2021.12.014","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T03:22:58Z","timestamp":1644636178000},"page":"815-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Missed Opportunities in Identifying Cardiomyopathy Aetiology Prior to Advanced Heart Failure Therapy"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3858-7356","authenticated-orcid":false,"given":"Norman","family":"Aiad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8382-3138","authenticated-orcid":false,"given":"Youssef A.","family":"Elnabawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-2559","authenticated-orcid":false,"given":"Boyangzi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navneet","family":"Narula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6596-2903","authenticated-orcid":false,"given":"Claudia","family":"Gidea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart D.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaline D.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Reyentovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tajinderpal","family":"Saraon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deane","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Moazami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.hlc.2021.12.014_bib1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.hlc.2021.12.014_bib2","first-page":"e48","article-title":"Do clinical diagnoses correlate with pathological diagnoses in cardiac transplant patients? The importance of endomyocardial biopsy","volume":"25","author":"Luk","year":"2009","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/j.hlc.2021.12.014_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jchf.2016.03.010","article-title":"Does survival on the heart transplant waiting list depend on the underlying heart disease?","volume":"4","author":"Hsich","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hlc.2021.12.014_bib4","series-title":"Verification of heart disease: implications for a new heart transplantation allocation system","author":"Raeisi-Giglou","year":"2017"},{"key":"10.1016\/j.hlc.2021.12.014_bib5","unstructured":"Optn, Unos. Proposal to Modify the Adult Heart Allocation System OPTN\/UNOS Thoracic Organ Transplantation Committee. https:\/\/optn.transplant.hrsa.gov\/media\/1244\/08_adult_heart_allocation_part1.pdf. [accessed 4.2.22]."},{"issue":"8","key":"10.1016\/j.hlc.2021.12.014_bib6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2015.03.012","article-title":"Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease","volume":"34","author":"Grupper","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.hlc.2021.12.014_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cardfail.2017.09.011","article-title":"Outcomes of restrictive and hypertrophic cardiomyopathies after LVAD: An INTERMACS analysis","volume":"23","author":"Patel","year":"2017","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.hlc.2021.12.014_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MAT.0000000000001238","article-title":"Left ventricular assist device implantation in hypertrophic and restrictive cardiomyopathy: a systematic review","volume":"67","author":"Sreenivasan","year":"2021","journal-title":"ASAIO J"},{"issue":"5","key":"10.1016\/j.hlc.2021.12.014_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"10.1016\/j.hlc.2021.12.014_bib10","doi-asserted-by":"crossref","first-page":"16212","DOI":"10.1038\/s41598-018-34648-5","article-title":"Impact of cardiovascular magnetic resonance imaging on identifying the etiology of cardiomyopathy in patients undergoing cardiac transplantation","volume":"8","author":"Lin","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.hlc.2021.12.014_bib11","first-page":"1","article-title":"Misdiagnosis of hATTR amyloidosis: a single US site experience","author":"Karam","year":"2019","journal-title":"Amyloid. October"},{"issue":"8","key":"10.1016\/j.hlc.2021.12.014_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11886-017-0876-4","article-title":"Adverse remodeling and reverse remodeling after myocardial infarction","volume":"19","author":"Bhatt","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"19","key":"10.1016\/j.hlc.2021.12.014_bib13","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","article-title":"Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis","volume":"107","author":"Koyama","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hlc.2021.12.014_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jacc.2005.10.061","article-title":"Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy","volume":"47","author":"Serri","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hlc.2021.12.014_bib15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ahj.2003.09.020","article-title":"Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy","volume":"147","author":"Ardehali","year":"2004","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.hlc.2021.12.014_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCHEARTFAILURE.112.000087","article-title":"Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000\u20132009","volume":"6","author":"Bennett","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"19","key":"10.1016\/j.hlc.2021.12.014_bib17","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2021.12.014_bib18","article-title":"Left ventricular assist device implantation in hypertrophic and restrictive cardiomyopathy: a systematic review","author":"Sreenivasan","year":"2020","journal-title":"Am Soc Artifical Intern Organs"},{"key":"10.1016\/j.hlc.2021.12.014_bib19","first-page":"52","article-title":"Reverse remodeling in dilated cardiomyopathy: insights and future perspectives","volume":"18","author":"Merlo","year":"2018","journal-title":"IJC Hear Vasc"},{"issue":"2","key":"10.1016\/j.hlc.2021.12.014_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.hfc.2017.12.001","article-title":"Genetic testing for cardiomyopathies in clinical practice","volume":"14","author":"Ingles","year":"2018","journal-title":"Heart Fail Clin"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:05:41Z","timestamp":1761415541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950622000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1443950622000269"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2021.12.014","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Missed Opportunities in Identifying Cardiomyopathy Aetiology Prior to Advanced Heart Failure Therapy","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2021.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}